Marijuana producer Maricann shares plunge on news of trading probe – Business

Shares of medical marijuana producer Maricann plunged more than 24 per cent on Wednesday after it revealed that a $70 million financing deal had been cancelled as it faces an investigation from the country’s biggest securities regulator.

Underwriters for a group of investment banks “orally” told the company that they will no longer go ahead with a share sale or bought deal that would have raised $70 million for Maricann, it said in a statement. 

The firm also said that several executives are being investigated by the Ontario Securities Commission (OSC) for the “timing and reporting of certain trades” of shares owned or controlled by directors Neil Tabatznik, Raymond Stone and Eric Silver.

“Stone, Tabatznik and Silver have advised the company that they are fully cooperating with the OSC in its review,” the firm said.

Both Tabatznik and Stone have resigned from the small cannabis producer in light of the probe.

The Toronto-based company has appointed director Paul Pathak as interim chairman of its board.

Management woes

Maricann also revealed that the OSC began investigating CEO Ben Ward on Feb. 8 for his “activities” while he was the head of another marijuana firm — Canadian Cannabis Corp.

“Prior to this, the company was unaware of the matter,” it said in a news release. 

“The company is unaware of any facts that could reasonably lead it to conclude that this investigation has had, or will have, any impact on the ability of Mr. Ward to properly and effectively carry out his duties as CEO or director of the company.”

The firm added that Ward was fully cooperating with the investigation. He was the head of Canadian Cannabis from 2013 to 2016.

Under review

Maricann said it has created a special committee, including an independent law firm, to review the trades and OSC investigation in an attempt to address concerns.

“We have heard from many significant shareholders of the company about their concerns with these matters, and we share them,” said Pathak. 

“The special committee’s review is ongoing, but we are committed to providing the stakeholders of the company with a further update on its review shortly,” he added.

The company’s shares were halted from trading on Tuesday in Toronto, but resumed trading today when it plummeted in the morning.

News of the investigations come at a time when scrutiny on Canada’s marijuana sector has increased in light of the young industry’s booming growth.

Maricann, similar to other new marijuana producers, have been seeing growing interest from investors to expand operations ahead of the Canadian government’s move to legalize the recreational use of the drug this summer.

Expansion deals have lead to stock valuations for producers to skyrocket in the past year, but share prices have taken a hit lately as companies face uncertainty over whether they can meet the demand.

Founded in 2013, Maricann has production facilities in Langton, Ontario and in Germany.

Source link

CBC News Canada

CBC News Canada

CBC News Canada is Canada's Online Information Source. Comprehensive web site for news, entertainment, sports, business, and a complete guide to CBC-TV, CBC Radio and CBC News Network
Buds2Go.ca is not responsible for, nor do we always share the opinions of the content posted on our website through our partners or independent authors.

Leave a Reply

What is a Sativa?

Sativa strains of medicinal marijuana are usually uplifting and stimulating. If you’ve ever smoked or ingested cannabis that makes everything funny and puts you in a great mood, it was probably from a Sativa strain. It creates a feeling of comfort, non-drowsy, and usually introspective highs. The effects of smoking or ingesting a Sativa makes them particularly popular among artists and creatives. The most popular medicinal benefits range from treating mental and behavioral problems, to treating depression, stress and ADHD.

What is an Indica?

The major difference between Sativa’s and Indica’s is while a Sativa can make you feel alert, active, and aware, an Indica will have a relaxing feel on the body. The physical effects of an Indica strain commonly include a drowsy and mellow mood with stress and pain relief. Indica’s are one of the more suggested strains when using it for medicinal purposes as it effectively treats sleeping disorders such as insomnia, fibromyalgia, body aches and pains. Indica’s are also commonly used for treating Multiple Sclerosis, Parkinson’s disease, Fibromyalgia and Lupus

Why Choose Hybrid?

The benefits to smoking or ingesting a Hybrid strain are simply as follows. Hybrid’s offer the best of both worlds combining several qualities of each containing strain. Some Hybrid’s are Indica dominant, which will offer pain relief and / or mellow mood, however may contain up to 50% Sativa so it will not make you too drowsy. Other’s may offer a Sativa dominant strain, which will encompass several calming benefits and pain relief, but also give a mellow, yet energetic high.

Why use Buds2Go?

We offer a guaranteed, reliable medicinal marijuana buying and shipping experience for our members. There are still thousands of people who don’t live in areas that are served by local dispensaries such as Vancouver and Victoria BC. We offer mail order marijuana in canada that is both fast and discreet and always include tracking numbers. Mail Order Medical Marijuana - Medicinal Cannabis Dispensary - Buy Weed Online